New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers report on inhibitory effect of glioblastoma signals to macrophages

Researchers report on inhibitory effect of glioblastoma signals to macrophages

by University of BaselGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0"Don't eat me," is how one might translate the signal that the cancer cells in a glioblastoma sen
Oncology February 18,2024
Researchers report on inhibitory effect of glioblastoma signals to macrophages

Researchers report on inhibitory effect of glioblastoma signals to macrophages

by University of BaselGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0"Don't eat me," is how one might translate the signal that the cancer cells in a glioblastoma sen
Oncology February 18,2024
New treatment trialed in mice offers hope for advanced liver cancer

New treatment trialed in mice offers hope for advanced liver cancer

by Centenary InstituteCD5-2 treatment improved tumor vessels structure. Representative scanning electron microscopy images of liver tumor blood vessels in the different treatment groups. Qualitat
Oncology February 18,2024
New treatment trialed in mice offers hope for advanced liver cancer

New treatment trialed in mice offers hope for advanced liver cancer

by Centenary InstituteCD5-2 treatment improved tumor vessels structure. Representative scanning electron microscopy images of liver tumor blood vessels in the different treatment groups. Qualitat
Oncology February 18,2024
No radiotherapy an option for older breast cancer patients, study shows

No radiotherapy an option for older breast cancer patients, study shows

by University of EdinburghCredit: Unsplash/CC0 Public DomainRadiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.The addition of radiothe
Oncology February 18,2024
No radiotherapy an option for older breast cancer patients, study shows

No radiotherapy an option for older breast cancer patients, study shows

by University of EdinburghCredit: Unsplash/CC0 Public DomainRadiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.The addition of radiothe
Oncology February 18,2024
Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q
Oncology February 18,2024
Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q
Oncology February 18,2024
Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

by Atrium Health Wake Forest BaptistCredit: Unsplash/CC0 Public DomainCancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. As metas
Oncology February 18,2024
Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

by Atrium Health Wake Forest BaptistCredit: Unsplash/CC0 Public DomainCancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. As metas
Oncology February 18,2024
Researchers create a cell therapy based on STAb cells for a type of leukemia with few treatment options

Researchers create a cell therapy based on STAb cells for a type of leukemia with few treatment options

by Josep Carreras Leukaemia Research InstituteComparative in vitro study of engineered CD1a-STAb and CD1a-CAR T cells. (A, B) Schematic diagrams showing the genetic (A) and domain structure (B) o
Oncology February 18,2024
Researchers create a cell therapy based on STAb cells for a type of leukemia with few treatment options

Researchers create a cell therapy based on STAb cells for a type of leukemia with few treatment options

by Josep Carreras Leukaemia Research InstituteComparative in vitro study of engineered CD1a-STAb and CD1a-CAR T cells. (A, B) Schematic diagrams showing the genetic (A) and domain structure (B) o
Oncology February 18,2024
Expansion of cell-to-cell communication drives early development of pancreatic cancer, finds new research

Expansion of cell-to-cell communication drives early development of pancreatic cancer, finds new research

by Ian Demsky,Memorial Sloan Kettering Cancer CenterA lens into epigenetic plasticity and its consequences on tumorigenesis. A genetically engineered mouse model enabled a longitudinal view of c
Oncology February 18,2024
Expansion of cell-to-cell communication drives early development of pancreatic cancer, finds new research

Expansion of cell-to-cell communication drives early development of pancreatic cancer, finds new research

by Ian Demsky,Memorial Sloan Kettering Cancer CenterA lens into epigenetic plasticity and its consequences on tumorigenesis. A genetically engineered mouse model enabled a longitudinal view of c
Oncology February 18,2024
Researchers identify immune cell that helps kill bladder cancer tumors

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp
Oncology February 18,2024
Researchers identify immune cell that helps kill bladder cancer tumors

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp
Oncology February 18,2024
Skin cancer rewires its energy systems to spread more efficiently, finds study

Skin cancer rewires its energy systems to spread more efficiently, finds study

by Queen Mary, University of LondonDifferent modes of migration and mitochondrial metabolism.a,bOxygen consumption rate (OCR) from cells embedded in a 3D collagen I matrix (n = 
Oncology February 18,2024
Skin cancer rewires its energy systems to spread more efficiently, finds study

Skin cancer rewires its energy systems to spread more efficiently, finds study

by Queen Mary, University of LondonDifferent modes of migration and mitochondrial metabolism.a,bOxygen consumption rate (OCR) from cells embedded in a 3D collagen I matrix (n = 
Oncology February 18,2024
Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

by Delthia Ricks , Medical XpressCredit: Unsplash/CC0 Public DomainJust as bacteria, viruses and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to ch
Oncology February 18,2024
Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why

by Delthia Ricks , Medical XpressCredit: Unsplash/CC0 Public DomainJust as bacteria, viruses and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to ch
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com